Literature DB >> 16429128

Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains.

Jaime Millán1, Lindsay Hewlett, Matthew Glyn, Derek Toomre, Peter Clark, Anne J Ridley.   

Abstract

During inflammation, leukocytes bind to the adhesion receptors ICAM-1 and VCAM-1 on the endothelial surface before undergoing transendothelial migration, also called diapedesis. ICAM-1 is also involved in transendothelial migration, independently of its role in adhesion, but the molecular basis of this function is poorly understood. Here we demonstrate that, following clustering, apical ICAM-1 translocated to caveolin-rich membrane domains close to the ends of actin stress fibres. In these F-actin-rich areas, ICAM-1 was internalized and transcytosed to the basal plasma membrane through caveolae. Human T-lymphocytes extended pseudopodia into endothelial cells in caveolin- and F-actin-enriched areas, induced local translocation of ICAM-1 and caveolin-1 to the endothelial basal membrane and transmigrated through transcellular passages formed by a ring of F-actin and caveolae. Reduction of caveolin-1 levels using RNA interference (RNAi) specifically decreased lymphocyte transcellular transmigration. We propose that the translocation of ICAM-1 to caveola- and F-actin-rich domains links the sequential steps of lymphocyte adhesion and transendothelial migration and facilitates lymphocyte migration through endothelial cells from capillaries into surrounding tissue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16429128     DOI: 10.1038/ncb1356

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  145 in total

Review 1.  Tumor-infiltrating lymphocytes and hepatocellular carcinoma: molecular biology.

Authors:  Nobuyoshi Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-10-06       Impact factor: 3.402

2.  Live-cell visualization of the trans-cellular mode of monocyte transmigration across the vascular endothelium, and its relationship with endothelial PECAM-1.

Authors:  Ken Hashimoto; Noriyuki Kataoka; Emi Nakamura; Kimiko Hagihara; Takeaki Okamoto; Hiroaki Kanouchi; Satoshi Mohri; Katsuhiko Tsujioka; Fumihiko Kajiya
Journal:  J Physiol Sci       Date:  2011-11-23       Impact factor: 2.781

Review 3.  Cellular communications in bone homeostasis and repair.

Authors:  Ken-Ichi Nakahama
Journal:  Cell Mol Life Sci       Date:  2010-08-08       Impact factor: 9.261

4.  Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation.

Authors:  Oliver Steiner; Caroline Coisne; Britta Engelhardt; Ruth Lyck
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-07       Impact factor: 6.200

Review 5.  Mechanisms of leukocyte transendothelial migration.

Authors:  William A Muller
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 6.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 7.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

Review 8.  Recent insights into endothelial control of leukocyte extravasation.

Authors:  Peter L Hordijk
Journal:  Cell Mol Life Sci       Date:  2016-01-21       Impact factor: 9.261

9.  Small Rho GTPase-mediated actin dynamics at endothelial adherens junctions.

Authors:  Jaap D van Buul; Ilse Timmerman
Journal:  Small GTPases       Date:  2016-01-29

10.  Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.

Authors:  Janet Hsu; Jeff Rappaport; Silvia Muro
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.